Universe Pharmaceuticals Inc.
UPCNASDAQHealthcare● Active
$3.62
+$0.35(+10.79%)
Market Cap$2040917
P/E Ratio—
52W High$11
52W Low$2
Universe Pharmaceuticals Inc. (UPC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · UPC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $17.86M | $23.02M | $32.31M | $40.14M | $47.98M |
| Cost of Revenue | $11.56M | $16.95M | $21.99M | $18.25M | $22.66M |
| Gross Profit | $6.30M | $6.07M | $10.32M | $21.89M | $25.33M |
| Gross Margin %(computed) | 35.28% | 26.37% | 31.93% | 54.53% | 52.78% |
| Operating Expenses | |||||
| R&D Expenses | $0.67M | $3.03M | $4.86M | $7.62M | $5.47M |
| G&A Expenses | $4.21M | $3.19M | $2.22M | $2.53M | $3.30M |
| Total Operating Expenses | $9.22M | $14.09M | $13.84M | $28.91M | $11.74M |
| Operating Income | ($2.92M) | ($8.02M) | ($3.53M) | ($7.02M) | $13.59M |
| Operating Margin %(computed) | -16.33% | -34.83% | -10.92% | -17.49% | 28.32% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.23M | $0.28M | $0.16M | $0.16M | $0.10M |
| Income Before Tax | ($3.67M) | ($8.12M) | ($3.94M) | ($7.98M) | $13.65M |
| Income Tax Expense | $0.00M | $0.61M | $2.25M | $0.75M | $2.36M |
| Net Income | ($3.67M) | ($8.73M) | ($6.16M) | ($8.74M) | $11.32M |
| Net Margin %(computed) | -20.56% | -37.90% | -19.08% | -21.76% | 23.59% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1055.75 | $-1436.12 | $-1040.53 | $-1475.02 | $2147.18 |
| Wtd Avg Shares | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M |
| EBITDA | ($2.92M) | ($7.36M) | ($3.18M) | ($6.40M) | $14.20M |
| EBITDA Margin %(computed) | -16.37% | -31.95% | -9.85% | -15.94% | 29.59% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Universe Pharmaceuticals Inc. data
About Universe Pharmaceuticals Inc. (UPC) Income Statement
Universe Pharmaceuticals Inc. (UPC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, UPC reported revenue of $0.02B, gross profit of $0.01B (gross margin 35.28%), and net income of ($0.00B) — a net profit margin of -20.56%.
Frequently asked questions
UPC · 4 questionsUniverse Pharmaceuticals Inc. (UPC) reported revenue of $0.02B for 2025, down 22.4% year-over-year.
UPC revenueUPC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09